Today is World Asthma Day! GINA emphasizes the need to empower people with asthma with the appropriate education to manage their disease - Asthma Education Empowers. Download the new 2024 report here: ginasthma.org/2024-report/ #WorldAsthmaDay #GINA #Asthma #AsthmaEducation

The goal of asthma treatment should be personalized for each patient, aiming for the patient’s best possible long-term outcomes. This includes both long-term symptom control and long-term risk reduction. Assessing recent symptom control is not enough. ginasthma.org/reports/

The 2024 GINA diagnostic flowchart for clinical practice has been revised.  Many health professionals don’t have access (or timely access) to spirometry. While less reliable than spirometry peak expiratory flow is better than relying on symptoms alone. ginasthma.org/reports

GINA UPDATE: an update of the GINA 2024 report was published on 22 May 2024, as we became aware that some medication doses for anti-inflammatory reliever therapy in Box 4-8 were being misread. Download the latest version from ginasthma.org/reports. Please share.

World No Tobacco Day 2024 Today on #WorldNoTobaccoDay FIRS is highlighting the dangers of novel tobacco products aimed at youth and condemns the tobacco industry's predatory marketing tactics. For more information, visit: ginasthma.org/world-no-tobac…

GINA 2024 provides recommendations about cough variant asthma which may be difficult to distinguish from other causes of chronic cough, since spirometry may be normal - treatment is the same as for asthma in general, with ICS-containing treatment. See ginasthma.org/reports

GINA 2024 clarifies that assessment of symptom control should not be limited to the last 4 weeks, and emphasizes that assessing symptom control is not enough. Risk factors for exacerbations, including past exacerbations, must also be assessed. ginasthma.org/reports

GINA 2024 key changes, based on evidence (where available) and consensus, include recommendations on the choice of initial treatment step for adults and adolescents. The GINA cycle of asthma management - asthma treatment is not just about medications. ginasthma.org/reports

GINA 2024 Risks of LTRA’s - risk of neuropsychiatric adverse events: A reminder to advise patients/parents/caregivers about risks including new-onset nightmares and behavioral problems and, in some cases, suicidal ideation. ginasthma.org/reports

World Bronchiectasis Day 2024 Today on #WorldBronchiectasisDay2024 FIRS is raising awareness by sharing knowledge, and discussing ways to reduce the burden of bronchiectasis for patients and their families worldwide. Learn more at worldbronchiectasisday.org

Asthma Reviews (routine & post-attack): GINA Asthma Management Cycle - three domains: Assess (including confirmation of diagnosis & identification of risks); Adjust (optimise care after assessment); Review to ensure the adjustments have been effective. ginasthma.org/reports

World Lung Cancer Day 2024 Today on #WorldLungCancerDay2024 FIRS stresses the importance of early screening awareness and access to diagnose and treat lung cancer. Learn more here: bit.ly/46tfXWq

There is strong evidence for prescribing combination inhaled corticosteroid-formoterol in one inhaler for relief of asthma symptoms in adults/adolescents. It reduces severe asthma attacks & emergency visits. Short-acting beta2-agonist relievers do not.www.ginasthma.org/reports

Please share this ‘bite - sized recommendation from GINA. FIRS -Forum of International Respiratory Societies GlobalAsthmaNetwork Asthma Society of Ireland Asthma.ca Asthma Council Aus

Confirming asthma diagnosis once inhaled corticosteroids (ICS) are started can be difficult. If asthma is well-controlled, stepping down ICS may help with diagnosis. Start with assessment – see highlighted section GINA 2024 Box 1-5. Full explanation at ginasthma.org/reports

Confirming asthma diagnosis once inhaled corticosteroids (ICS) are started can be difficult. If asthma is well-controlled, stepping down ICS may help. After assessment, reduce dose and book review – see highlighted section Box 1-5. Full explanation at ginasthma.org/reports